Balaji Gandhi Sells 5,771 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 5,771 shares of the firm’s stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $30.04, for a total value of $173,360.84. Following the completion of the sale, the chief financial officer now directly owns 105,514 shares in the company, valued at approximately $3,169,640.56. The trade was a 5.19 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link.

Balaji Gandhi also recently made the following trade(s):

• On Thursday, February 13th, Balaji Gandhi sold 28,759 shares of Phreesia stock. The shares were sold at an average price of $30.00, for a total value of $862,770.00.
• On Monday, January 27th, Balaji Gandhi sold 4,813 shares of Phreesia stock. The shares were sold at an average price of $27.48, for a total transaction of $132,261.24.
• On Tuesday, January 21st, Balaji Gandhi sold 5,827 shares of Phreesia stock. The stock was sold at an average price of $27.31, for a total transaction of $159,135.37.
• On Wednesday, January 15th, Balaji Gandhi sold 836 shares of Phreesia stock. The shares were sold at an average price of $26.98, for a total transaction of $22,555.28.
• On Monday, January 6th, Balaji Gandhi sold 3,195 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total transaction of $85,018.95.

Phreesia Price Performance

Phreesia stock opened at $28.20 on Friday. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The company has a 50-day moving average price of $27.29 and a 200 day moving average price of $23.84. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $30.53. The stock has a market cap of $1.64 billion, a P/E ratio of -19.18 and a beta of 0.96.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.04. The business had revenue of $106.80 million during the quarter, compared to analysts’ expectations of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business’s revenue for the quarter was up 16.6% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.58) EPS. Sell-side analysts anticipate that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Analyst Upgrades and Downgrades

PHR has been the subject of several research reports. Truist Financial boosted their price objective on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and boosted their price target for the stock from $24.00 to $32.00 in a research report on Wednesday, January 8th. Needham & Company LLC reissued a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a research note on Friday, January 10th. Citigroup lifted their target price on shares of Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a research note on Friday, January 10th. Finally, KeyCorp upped their target price on shares of Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a report on Wednesday, January 8th. Thirteen analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $31.15.

Institutional Investors Weigh In On Phreesia

Several hedge funds and other institutional investors have recently added to or reduced their stakes in PHR. Versor Investments LP acquired a new position in shares of Phreesia in the 3rd quarter valued at $694,000. Zacks Investment Management acquired a new position in Phreesia in the third quarter valued at about $631,000. State Street Corp lifted its position in Phreesia by 7.1% in the third quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after buying an additional 88,517 shares during the last quarter. Wesbanco Bank Inc. boosted its stake in Phreesia by 76.9% during the fourth quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company’s stock worth $1,157,000 after buying an additional 20,000 shares during the period. Finally, Barclays PLC increased its position in shares of Phreesia by 83.6% during the third quarter. Barclays PLC now owns 94,929 shares of the company’s stock valued at $2,163,000 after acquiring an additional 43,225 shares during the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.